Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Aura Biosciences, Inc. (AURA) had Return on Investments of -18.67% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-25.56M |
|
-- |
|
-- |
|
$27.24M |
|
$-27.24M |
|
$1.69M |
|
$-25.54M |
|
$-25.54M |
|
$-25.56M |
|
$-25.56M |
|
$-25.56M |
|
$-25.56M |
|
$-27.24M |
|
$-26.96M |
|
60.34M |
|
60.34M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$149.74M |
|
$2.62M |
|
$19.69M |
|
$169.43M |
|
$18.38M |
|
-- |
|
$14.13M |
|
$32.52M |
|
$136.91M |
|
$136.91M |
|
$136.91M |
|
63.59M |
|
| Cash Flow Statement Financials | |
$-84.74M |
|
$35.59M |
|
$77.16M |
|
$32.46M |
|
$60.28M |
|
$27.82M |
|
$14.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-85.19M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.67% |
|
-18.67% |
|
-15.09% |
|
|
Return on Investments |
-18.67% |
$2.15 |
|
$-1.41 |
|
$-1.40 |
|